Sol-Gel Technologies
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell SLGL and other ETFs, options, and stocks.About SLGL
Sol-Gel Technologies Ltd. operates as a clinical-stage dermatology company, which engages in the identification, development, and commercialization of topical dermatological drug products for the treatment of skin diseases. Its products include VERED, TWIN, and SIRS-T.
CEOMoshe Arkin
CEOMoshe Arkin
Employees34
Employees34
HeadquartersNess Ziona, Tel Aviv
HeadquartersNess Ziona, Tel Aviv
Founded1997
Founded1997
Employees34
Employees34
SLGL Key Statistics
Market cap111.57M
Market cap111.57M
Price-Earnings ratio-12.56
Price-Earnings ratio-12.56
Dividend yield—
Dividend yield—
Average volume18.50K
Average volume18.50K
High today$40.70
High today$40.70
Low today$38.31
Low today$38.31
Open price$40.60
Open price$40.60
Volume16.53K
Volume16.53K
52 Week high$52.26
52 Week high$52.26
52 Week low$4.02
52 Week low$4.02
Stock Snapshot
With a market cap of 111.57M, Sol-Gel Technologies(SLGL) trades at $40.11. The stock has a price-to-earnings ratio of -12.56.
On 2025-12-05, Sol-Gel Technologies(SLGL) stock traded between a low of $38.31 and a high of $40.70. Shares are currently priced at $40.11, which is +4.7% above the low and -1.4% below the high.
The Sol-Gel Technologies(SLGL)'s current trading volume is 16.53K, compared to an average daily volume of 18.5K.
During the past year, Sol-Gel Technologies(SLGL) stock moved between $4.02 at its lowest and $52.26 at its peak.
During the past year, Sol-Gel Technologies(SLGL) stock moved between $4.02 at its lowest and $52.26 at its peak.
People also own
Based on the portfolios of people who own SLGL. This list is generated using Robinhood data, and it’s not a recommendation.